LABU vs. UCO
Compare and contrast key facts about Direxion Daily S&P Biotech Bull 3x Shares (LABU) and ProShares Ultra Bloomberg Crude Oil (UCO).
LABU and UCO are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. LABU is a passively managed fund by Direxion that tracks the performance of the S&P Biotechnology Select Industry Index (300%). It was launched on May 28, 2015. UCO is a passively managed fund by ProShares that tracks the performance of the Dow Jones-UBS Crude Oil Sub-Index (200%). It was launched on Nov 24, 2008. Both LABU and UCO are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LABU or UCO.
Key characteristics
| LABU | UCO | |
|---|---|---|
| YTD Return | -3.63% | 21.49% |
| 1Y Return | -11.42% | 28.64% |
| 3Y Return (Ann) | -54.20% | 24.45% |
| 5Y Return (Ann) | -32.90% | -26.40% |
| Sharpe Ratio | -0.12 | 0.79 |
| Daily Std Dev | 82.23% | 47.01% |
| Max Drawdown | -98.92% | -99.95% |
| Current Drawdown | -97.44% | -99.49% |
Correlation
The correlation between LABU and UCO is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
LABU vs. UCO - Performance Comparison
In the year-to-date period, LABU achieves a -3.63% return, which is significantly lower than UCO's 21.49% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LABU vs. UCO - Expense Ratio Comparison
LABU has a 1.12% expense ratio, which is higher than UCO's 0.95% expense ratio.
Risk-Adjusted Performance
LABU vs. UCO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bull 3x Shares (LABU) and ProShares Ultra Bloomberg Crude Oil (UCO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
LABU vs. UCO - Dividend Comparison
LABU's dividend yield for the trailing twelve months is around 0.50%, while UCO has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
LABU Direxion Daily S&P Biotech Bull 3x Shares | 0.50% | 0.35% | 0.00% | 0.00% | 0.00% | 0.28% | 0.64% | 0.17% |
UCO ProShares Ultra Bloomberg Crude Oil | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
LABU vs. UCO - Drawdown Comparison
The maximum LABU drawdown since its inception was -98.92%, roughly equal to the maximum UCO drawdown of -99.95%. Use the drawdown chart below to compare losses from any high point for LABU and UCO. For additional features, visit the drawdowns tool.
Volatility
LABU vs. UCO - Volatility Comparison
Direxion Daily S&P Biotech Bull 3x Shares (LABU) has a higher volatility of 20.50% compared to ProShares Ultra Bloomberg Crude Oil (UCO) at 8.30%. This indicates that LABU's price experiences larger fluctuations and is considered to be riskier than UCO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.